Joseph G. Naglich

Expression cloning of a diphtheria toxin receptor: Identity with a heparin-binding EGF-like growth factor precursor

Joseph G. Naglich, James E. Metherall, David W. Russell et al. · Cell · 1992 · 543 citations

Protein Function, Signal Transduction, Signaling Pathway +7

Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.

Jean M. Whaley, Joseph G. Naglich, Lawrence M. Gelbert et al. · PubMed · 1994 · 237 citations

Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity

Catherine Blankenship, Joseph G. Naglich, Jean M. Whaley et al. · Oncogene · 1999 · 140 citations

Initiation Codon, Alternate Choice, Oncogenic Agent +9

Inhibition of angiogenesis and metastasis in two murine models by the matrix metalloproteinase inhibitor, BMS-275291.

Joseph G. Naglich, Maria Jure‐Kunkel, Elora Gupta et al. · PubMed · 2001 · 114 citations

Matrix Metalloproteinase Inhibitor, Immunology, Pathology +19

The Discovery of Macrocyclic XIAP Antagonists from a DNA-Programmed Chemistry Library, and Their Optimization To Give Lead Compounds with in Vivo Antitumor Activity

Benjamin A. Seigal, William H. Connors, Andrew W. Fraley et al. · Journal of Medicinal Chemistry · 2015 · 85 citations · Full text

Lead Compounds, Molecular Biology, Lead Identification +21